Clinical Trial Update: The Effect of Oxygen Therapy on 6MWD in PAH and CTEPH Patients With Hypoxemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating whether supplemental oxygen improves six-minute walk distance in hypoxemic patients with pulmonary arterial hypertensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Oxygen therapy (Oxygen)

Snippet

Sponsor: Heidelberg University | Conditions: Oxygen Deficiency, Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED